IRIS
BUCCI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.948
NA - Nord America 3.538
AS - Asia 1.754
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 5
OC - Oceania 4
Totale 9.270
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.522
IT - Italia 1.129
CN - Cina 657
SG - Singapore 584
IE - Irlanda 579
UA - Ucraina 476
SE - Svezia 474
FR - Francia 423
TR - Turchia 328
GB - Regno Unito 302
DE - Germania 255
IN - India 138
FI - Finlandia 105
RU - Federazione Russa 90
BE - Belgio 25
PL - Polonia 15
CA - Canada 13
IR - Iran 10
NL - Olanda 10
CH - Svizzera 9
CZ - Repubblica Ceca 9
EG - Egitto 9
GR - Grecia 9
EU - Europa 8
ES - Italia 7
LT - Lituania 7
HK - Hong Kong 6
IL - Israele 6
VN - Vietnam 6
ID - Indonesia 5
MY - Malesia 5
AL - Albania 3
AU - Australia 3
BR - Brasile 3
MX - Messico 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
DK - Danimarca 2
EE - Estonia 2
JP - Giappone 2
LV - Lettonia 2
NO - Norvegia 2
PK - Pakistan 2
RO - Romania 2
TH - Thailandia 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BG - Bulgaria 1
CL - Cile 1
EC - Ecuador 1
HU - Ungheria 1
KR - Corea 1
MC - Monaco 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
ZA - Sudafrica 1
Totale 9.270
Salva come PNG Salva come JPEG
Città #
Chandler 720
Jacksonville 565
Dublin 560
Singapore 513
Princeton 254
Southend 222
Izmir 197
Nanjing 157
Ashburn 139
Beijing 132
Ann Arbor 119
Wilmington 110
Dearborn 97
Santa Clara 94
Cambridge 92
Chieti 89
New York 83
Boardman 69
Nanchang 63
Altamura 62
Munich 57
Los Angeles 56
Pescara 55
Milan 54
Rome 42
Woodbridge 40
Shenyang 35
Hebei 31
Foggia 30
Helsinki 30
Tianjin 30
Washington 28
Houston 27
Brussels 24
Jinan 21
Kunming 19
Norwalk 17
Zhengzhou 15
Grevenbroich 14
Hangzhou 14
Ningbo 13
Auburn Hills 12
Changsha 12
Florence 12
Jiaxing 12
Bologna 11
Guangzhou 11
Orange 11
Kraków 10
London 10
San Mateo 10
Taizhou 10
Frankfurt am Main 9
Moscow 9
Seattle 9
Toronto 9
Bari 8
Brno 8
Lanzhou 8
Mountain View 8
Catania 7
Changchun 7
Padova 7
Spoltore 7
Andover 6
Augusta 6
Campobasso 6
Catanzaro 6
Falls Church 6
Nocera Inferiore 6
Nuremberg 6
Simi Valley 6
Dong Ket 5
Grugliasco 5
Hefei 5
Legnano 5
Napoli 5
Sala Baganza 5
San Vito Chietino 5
Shanghai 5
Athens 4
Brescia 4
Carini 4
Genoa 4
Giugliano in Campania 4
Laurel 4
Lausanne 4
Monmouth Junction 4
Montesilvano Marina 4
Naples 4
Notaresco 4
Pisa 4
Pomezia 4
Pontedera 4
Turin 4
Venice 4
Verona 4
Weston-super-Mare 4
Abbiategrasso 3
Bergamo 3
Totale 5.372
Salva come PNG Salva come JPEG
Nome #
Indici di rigidità arteriosa e rischio cardiovascolare globale: risultati da una popolazione abruzzese in prevenzione primaria 473
Comparison between Dutch Lipid Clinic Network (DLCN) criteria, Simon Broome register group (SB) and US MedPed Program diagnostic performance in a pediatric cohort from LIPIGEN study population: preliminary data. 156
VALUTAZIONE FUNZIONALE DELL'ATLETA: RAPPORTI TRA VO2 MAX E COMPOSIZIONE CORPOREA 136
Uneven accuracy of home blood pressure measurement: a multi-centric survey 126
(Dis)-agreement among Cardiovascular Risk Calculators in clinical practice 125
Differences in blood pressure according to body position (supine, Fowler’s and sitting) in hypertensive subjects 111
OVEREXPRESSION OF TOLL LIKE RECEPTOR 4 AS A BASIS OF CYCLOOXYGENASE 2-DEPENDENT ATHEROSCLEROTIC PLAQUE INSTABILITY IN HUMANS. 109
A short-term vs a long-term infusion plan. A 20-week, European randomized trial. Analysis of efficacy and costs. 109
Long-term Positivity to SARS-CoV-2: A Clinical Case of COVID-19 with Persistent Evidence of Infection 108
Risultati immediati ed a lungo termine della rivascolarizzazione coronarica con PTCA con carattere ad autoperfusione vs PTCA con impianto di stent intracoronarico. 105
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 104
A unique microRNA signature associated with ischemic stroke in humans 101
Pressure and microcirculatory effects of treatment with lercanidipine in hypertensive patients and in vascular patients with hypertension 99
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteases activity 99
A unique microRNA signature associated with plaque instability in humans. 97
Linee guida cliniche per la prevenzione della cardiopatia ischemica nella ipercolesterolemia familiare: una patologia sotto-diagnosticata e sotto-trattata. Consensus. 96
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. 95
Total triterpenic fraction of Centella asiatica in chronic venous insufficiency and in high-perfusion microangiopathy. 94
Bioequivalence study of two tablet formulations of ramipril in healthy volunteers 93
[Controllo dei fattori di rischio cardiovascolare nella comune pratica clinica in un campione di pazienti in prevenzione secondaria rappresentativo della popolazione abruzzese] 92
Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients 92
PGE(1) treatment of severe intermittent claudication (short-term versus long-term, associated with exercise)--efficacy and costs in a 20-week, randomized trial 92
ATP-binding cassette transporter A1 (ABCA1) overexpression in hypercholesterolemic plaques: a potential molecular explanation 91
Evaluation of treatment of diabetic microangiopathy with total triterpenic fraction of Centella Asiatica: a clinical prospective randomized trial with a microcirculatory model. 89
MicroRNA profiling reveals new potential modulators of insulin-resistance and cardiovascular risk in type 2 diabetes 89
uFollow-Up clinico di un gruppo di pazienti sottoposti a PTCA con impianto di stent intracoronarico. 88
Single coronary artery with a right origin: angiography identification of the R-II subgroup] 88
La gestione del profilo lipidico nei pazienti in prevenzione secondaria sul territorio: lo studio ELL 88
Reduced TIA-1 expression in vulnerable atherosclerotic plaques as a basis of cyclooxygenase-2-dependent plaque instability in humans. 87
The diagnostic performance of the Italian Society for the Study of Atherosclerosis (SISA)-modified Dutch Lipid Clinic Network (DLCN) criteria in a pediatric cohort from LIPIGEN study population: preliminary data 87
PROGETTO DI SCREENING SU 24.000 SOGGETTI IN ETA' SCOLARE DELL'OBBLIGO DELLA PROVINCIA DI PESCARA. DATI PRELIMINARI. 87
Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control 86
Ipertensione arteriosa ed algosensibilità muscolare 85
L’automisurazione domiciliare della pressione: istruzioni per l’uso e sua utilità nel paziente anziano 85
A case of coinfection with SARS-COV-2 and Cytomegalovirus in the Era of Covid-19 85
Total triterpenic fraction of Centella asiatica in the treatment of venous hypertension: a clinical, prospective, randomized trial using a combined microcirculatory model. 84
Association between 5-lipoxygenase expression and plaque instability in humans. 84
Overexpression of ABCA1 in human plaques exposed to hypercholesterolemia: the role of microRNA modulation 83
Efficacy of a nurse-led email reminder program for cardiovascular prevention risk reduction in hypertensive patients: a randomized controlled trial. 83
The (K+)ey of the problem 83
MicroRNA profiling reveals new potential modulators of insulin-resistance in type 2 Diabetes 82
Ensuring Longer Life Study. A new model for an integrated management of patients at high cardiovascular risk. 81
High dose rosuvastatin increases ABCA1 transporter in human atherosclerotic plaques in a cholesterol-independent fashion 81
LDL-Apheresis abruzzo network: an old-new opportunity for the management of patients at high cardiovascular risk. 80
ABCA-1 Expression is reduced in atherosclerotic plaques of hypertensive patient: a new link between hypertension and atherosclerosis 80
[European trial of PGE1 alpha cyclodextrin. Short-term vs. long-term therapy in intermittent claudication] 79
Hypertension is a determinant of ABCA1 expression in atherosclerotic plaques from hypercholesterolemic patients 79
Nomograms used to define the short-term treatment with PGE(1) in patients with intermittent claudication and critical ischemia. The ORACL.E (Occlusion Revascularization in the Atherosclerotic Critical Limb) Study Group. The European Study. 78
From Endothelium to Lipids, Through microRNAs and PCSK9: A Fascinating Travel Across Atherosclerosis 78
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 78
HUR protein contributes to modulation of angiotensin ii type 1 receptor expression in human atherosclerotic plaque. 77
HuR protein as potential modulator of angiotensin II type 1 receptor expression in human atherosclerotic plaque. 77
MicroRNA profiling reveals new potetial modulators of insulin resistance and cardiovascular risk in type 2 diabetes 77
Rosuvastatin reduces Matrix Metalloproteinase (MMP)-9 and Plasminogen Activator Inhibitor (PAI)-1 expression via a microRNA-dependent pathway 77
DISAGREEMENT AMONG THE MAIN ALGORITHMS FOR CARDIOVASCULAR RISK ESTIMATION IN PATIENTS STRATIFICATION AND IN THEIR CORRELATION WITH ARTERIAL STIFFNESS 77
Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes 76
Possible indication of coronary risk trough discriminant functions. 74
Angiotensin II Blockade and Total Cardiovascular Risk. Beyond Blood Pressure Reduction. 74
Artrite reumatoide ed aumentato rischio cardiovascolare: impatto delle differenti terapie farmacologiche
 [Rheumatoid arthritis and increased cardiovascular risk: role of the different pharmacological therapies] 74
PROGETTO DI SCREENING SU 24OOO SOGGETTI IN ETA' SCOLARE DELL'OBBLIGO DELLA PROVINCIA DI PESCARA. DATI PRELIMINARI 74
ABCA-1 expression is reduced in atherosclerotic plaques from hypertensive patients: a new potential link between hypertension and atherosclerosis 73
Treatment of Diabetic Microangiopathy and Edema with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled Randomized Study. 72
La stratificazione del rischio di sviluppare Diabete Mellito come strumento di diagnosi precoce: lo studio DIGA 72
Effect of Rosuvastatin on MicroRNAs expression in human atherosclerotic plaques: results from Quasar Study 72
Microcirculatory Effects of Total Triterpenic Fraction of Cenetlla asiatica in Chronic Venous Hypertension: Measurement by Laser Doppler, TcPo2-CO2, and Leg Volumetry 71
Hypertension modulates miR-145 expression in human atherosclerotic plaques 71
null 71
[ANALYSIS OF COSTS AND RESULTS OF PROSTAGLANDIN (PGE1 ALPHA-CYCLODESTRIN) THERAPY OF PERIPHERAL ARTERIAL DISEASES] 71
Arterial stiffness and global cardiovascular risk: results from a primary prevention population from Abruzzo (Italy) 70
Oxygen-free radical decrease in hypertensive patients treated with lercanidipine 69
Cardiovascular risk factor control in common clinical practice in a sample of patients in secondary prevention representative of the Abruzzo population 69
Muscle pain sensitivity in hypertensive patients with and without chronic pain 69
Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10 year follow-up study (the CAFES-CAVE Study). 68
Treatment of long-distance intermittent claudication with pentoxifylline: a 12-month, randomized trial. 68
Increase in Echogenicity of Echolucent Carotid Plaques After Treatment with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled, Randomized Trial. 68
Impact of hypertension on somatic pain sensitivity in chronic headache 68
Improvement of Inflammation and Pain after Three Months’ Exclusion Diet in Rheumatoid Arthritis Patients 68
HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial. 67
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 67
24-months follow-up to assess the efficacy and tolerability of evolocumab in a young patient with chronic and progressive ischemic arteriopathy 67
Cyclooxygenase and prostaglandin synthases in atherosclerosis: Recent insights and future perspectives 67
COVID-19 and RAS: Unravelling an Unclear Relationship 66
Cost-effectiveness of statins in primary and secondary prevention of cardiovascular event 65
Lp(a) and cardiovascular risk: Investigating the hidden side of the moon 65
[Reduction of cardiovascular morbidity/mortality in arteriopathies treated ith PGE1 alpha-cyclodextrin] 63
Subcutaneous adipose tissue elastosonography in obese patients: a preliminary report 63
Treatment of intermittent claudication with pentoxifylline: A 12-month, randomized trial: Walking distance and microcirculation 62
null 61
Correlation between Dutch lipid score and genetic diagnosis of FH in pediatric patients 61
Efficacy and safety of piroxicam patch versus piroxicam cream in patients with lumbar osteoarthritis. A randomized, placebo-controlled study 60
A case of coinfection with SARS-Cov-2 and cytomegalovirus in the era of Covid-19. 60
LA MALATTIA DI BARLOW NELLO SPORTIVO: TECNICA CHIRURGICA INNOVATIVA 59
Effects of lifestyle treatment on patients with metabolic syndrome and non-alcoholic hepatic steatosis evaluated with an ultrasonographic and elastographic approach 59
The fascinating relationship between liver stiffness and cholesterol 58
Effects of the total triterpenic fraction of Centella asiatica in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial 57
Cardiovascular morbidity/mortality modified by the use of FGE1 alpha-cyclodextran and calcium heparin in patients with severe vascular diseases 57
Effects of Rosuvastatin on the expression of microRNAs and their putative targets in human atherosclerotic plaques: the QUASAR Study 57
When a timely diagnosis means life: a precious lesson from a clinical case 56
Microcirculatory effects of total triterpenic fraction of Centella asiatica in chronic venous hypertension: measurement by laser Doppler, TcPO2-CO2, and leg volumetry. 55
Impatto metabolico della terapia antiipertensiva nel paziente dislipidemico 55
Totale 8.414
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.842
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.842
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020867 0 0 0 0 0 104 155 128 76 173 170 61
2020/2021829 116 15 118 36 64 149 35 38 82 90 36 50
2021/2022744 34 20 22 153 39 14 28 39 62 29 122 182
2022/20232.129 165 256 119 223 214 414 130 159 274 44 70 61
2023/20241.188 82 44 75 40 85 333 225 44 35 64 25 136
2024/20251.209 133 449 356 74 103 94 0 0 0 0 0 0
Totale 9.752